Join
Live feed
·
INSIDERFilingvia Quantisnow
Lipella Pharmaceuticals Inc. logo

Kaufman Jonathan H was granted 144,906 shares, increasing direct ownership by 21% to 833,849 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
LIPO· Lipella Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LIPO (Lipella Pharmaceuticals Inc.) and more on Quantisnow.